Almost $1 billion: F&P defies market chatter

Almost $1 billion: F&P defies market chatter
Managing director Lewis Gradon said the first half of the last financial year was a period of extraordinary demand during the initial surges of covid-19. (Image: supplied)
Staff reporters
Fisher & Paykel Healthcare has reported half-year revenue down just 1% to $900 million, defying analyst expectations of a significant sales slowdown. Investors have been waiting since August to get an update on how the company is tracking, with management unable to offer guidance due to unpredictable sales during the pandemic.Analysts from two of New Zealand’s largest broking firms predicted a revenue decline between 7% and 9% as covid-related sales normalised.Instead, the healthcare exporter’s revenue dropped just 1% in th...

More Markets

Home-loan rivalry set to spice up as ANZ loses market share
Finance

Home-loan rivalry set to spice up as ANZ loses market share

ANZ NZ's underlying full-year profit eases higher as it eyes home-loan offering. 

NZX flat after Vital announcement
Markets

NZX flat after Vital announcement

The NZX was flat, but property stocks declined more than 1%.

Graham Skellern 10 Nov 2025
Economic hedges help ANZ NZ lift annual profit
Finance

Economic hedges help ANZ NZ lift annual profit

ANZ NZ styles its full-year results as solid as net-interest margin nudges higher.

Andy Macdonald 10 Nov 2025
PaySauce shares rise as it eyes Australia
Markets

PaySauce shares rise as it eyes Australia

Customer numbers for micro and rural payroll firm increased 9% for six months to Sept 30.